General Information
The European Association of Nuclear Medicine (EANM) is the largest organisation dedicated to nuclear medicine in Europe. In this role, the EANM has become the umbrella organisation representing the whole sector towards European institutions and other international organisations.
Vision, Mission and Goals
The EANM’s vision is to optimise and advance science and education in nuclear medicine for the benefit of public health and humanity within the concept of personalised healthcare. The EANM acts as the umbrella organisation for individuals and national societies.
The goal of the EANM is to be a platform for the dissemination and discussion of the latest results in the field of nuclear medicine, including multimodality imaging and related subjects. It fosters and coordinates the mutual exchange of knowledge relating to the diagnosis and treatment of diseases through using unsealed radioactive substances and the properties of stable nuclides in medicine.
History and Background
The EANM is a professional non-profit medical association incorporated in Vienna, Austria. The organisation was founded on September 6, 1985, in London as a result of the fusion of the Society of Nuclear Medicine Europe and the European Nuclear Medicine Society. The first congress of the EANM took place in 1988 in Milan, Italy.
The merging of the two societies is still reflected within the EANM, as the association simultaneously acts as a forum for individual members (who convene annually at the Members’ Assembly) and for the nuclear medicine societies of Europe (which convene at the Delegates’ Assembly). This twin-track approach guarantees that the EANM serves the needs of individual members but also has a strong awareness of the challenges faced by nuclear medicine in European countries.
As of 2022, the EANM membership represents 40 European National Societies, and comprises 2,900 individual members from 80 countries from Europe and beyond, who are physicians, scientists, technologists and other health professionals working in nuclear medicine or related fields. In addition, the EANM closely works in collaboration with 20 non-European Affiliated Societies. The EANM is also supported by a team of over 150 volunteers, who works within the Board and the Committees.
The EANM has also gained renown for its Annual Congress, which attracts over 7,000 participants each year. The EANM Annual Congress offers a unique platform to explore the latest advancements, innovations, and breakthroughs in nuclear medicine, and brings together leading experts, researchers, professionals and policymakers from around the world.